Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Helen DeVos Children's Hospital at Spectrum Health
1839
mi
from 91732
Grand Rapids, MI
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Helen DeVos Children's Hospital at Spectrum Health
1839
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Masonic Cancer Center at University of Minnesota
1511
mi
from 91732
Minneapolis, MN
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Masonic Cancer Center at University of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Mayo Clinic Cancer Center
1524
mi
from 91732
Rochester, MN
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Mayo Clinic Cancer Center
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
University of Mississippi Cancer Clinic
1608
mi
from 91732
Jackson, MS
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
University of Mississippi Cancer Clinic
1608
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Ellis Fischel Cancer Center at University of Missouri - Columbia
1459
mi
from 91732
Columbia, MO
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Ellis Fischel Cancer Center at University of Missouri - Columbia
1459
mi
from 91732
Columbia, MO
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Children's Mercy Hospital
1341
mi
from 91732
Kansas City, MO
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Children's Mercy Hospital
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
John Theurer Cancer Center
2429
mi
from 91732
Hackensack, NJ
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
John Theurer Cancer Center
2429
mi
from 91732
Hackensack, NJ
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Overlook Hospital
2407
mi
from 91732
Morristown, NJ
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Overlook Hospital
2407
mi
from 91732
Morristown, NJ
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Newark Beth Israel Medical Center
2423
mi
from 91732
Newark, NJ
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Newark Beth Israel Medical Center
2423
mi
from 91732
Newark, NJ
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
St. Joseph's Hospital and Medical Center
2423
mi
from 91732
Paterson, NJ
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
St. Joseph's Hospital and Medical Center
2423
mi
from 91732
Paterson, NJ
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
2435
mi
from 91732
New York, NY
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
SUNY Upstate Medical University Hospital
2320
mi
from 91732
Syracuse, NY
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
SUNY Upstate Medical University Hospital
2320
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Blumenthal Cancer Center at Carolinas Medical Center
2102
mi
from 91732
Charlotte, NC
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Blumenthal Cancer Center at Carolinas Medical Center
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Presbyterian Cancer Center at Presbyterian Hospital
2102
mi
from 91732
Charlotte, NC
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Presbyterian Cancer Center at Presbyterian Hospital
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Cleveland Clinic Taussig Cancer Center
2033
mi
from 91732
Cleveland, OH
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Cleveland Clinic Taussig Cancer Center
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Rainbow Babies and Children's Hospital
2036
mi
from 91732
Cleveland, OH
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Rainbow Babies and Children's Hospital
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Nationwide Children's Hospital
1961
mi
from 91732
Columbus, OH
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Nationwide Children's Hospital
1961
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Dayton Children's
1898
mi
from 91732
Dayton, OH
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Dayton Children's
1898
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Children's Hospital of Pittsburgh of UPMC
2121
mi
from 91732
Pittsburgh, PA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Children's Hospital of Pittsburgh of UPMC
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Palmetto Health South Carolina Cancer Center
2105
mi
from 91732
Columbia, SC
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Palmetto Health South Carolina Cancer Center
2105
mi
from 91732
Columbia, SC
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Greenville Hospital Cancer Center
2018
mi
from 91732
Greenville, SC
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Greenville Hospital Cancer Center
2018
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Vanderbilt-Ingram Cancer Center
1762
mi
from 91732
Nashville, TN
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Vanderbilt-Ingram Cancer Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Driscoll Children's Hospital
1295
mi
from 91732
Corpus Christi, TX
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Driscoll Children's Hospital
1295
mi
from 91732
Corpus Christi, TX
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
1225
mi
from 91732
Dallas, TX
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Baylor University Medical Center - Houston
1357
mi
from 91732
Houston, TX
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Baylor University Medical Center - Houston
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Primary Children's Medical Center
573
mi
from 91732
Salt Lake City, UT
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Primary Children's Medical Center
573
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Children's Hospital of The King's Daughters
2336
mi
from 91732
Norfolk, VA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Children's Hospital of The King's Daughters
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Carilion Medical Center for Children at Roanoke Community Hospital
2133
mi
from 91732
Roanoke, VA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Carilion Medical Center for Children at Roanoke Community Hospital
2133
mi
from 91732
Roanoke, VA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Providence Cancer Center at Sacred Heart Medical Center
938
mi
from 91732
Spokane, WA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Providence Cancer Center at Sacred Heart Medical Center
938
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Marshfield Clinic - Marshfield Center
1645
mi
from 91732
Marshfield, WI
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Marshfield Clinic - Marshfield Center
1645
mi
from 91732
Marshfield, WI
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Midwest Children's Cancer Center at Children's Hospital of Wisconsin
1722
mi
from 91732
Milwaukee, WI
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Midwest Children's Cancer Center at Children's Hospital of Wisconsin
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Children's Hospital Colorado Center for Cancer and Blood Disorders
825
mi
from 91732
Aurora, CO
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Children's Hospital Colorado Center for Cancer and Blood Disorders
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
UMASS Memorial Cancer Center - University Campus
2540
mi
from 91732
Worcester, MA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
UMASS Memorial Cancer Center - University Campus
2540
mi
from 91732
Worcester, MA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
C.S. Mott Children's Hospital at University of Michigan Medical Center
1934
mi
from 91732
Ann Arbor, MI
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
C.S. Mott Children's Hospital at University of Michigan Medical Center
1934
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
1570
mi
from 91732
St. Louis, MO
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
CCOP - Nevada Cancer Research Foundation
217
mi
from 91732
Las Vegas, NV
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
CCOP - Nevada Cancer Research Foundation
217
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
2410
mi
from 91732
New Brunswick, NJ
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
James P. Wilmot Cancer Center at University of Rochester Medical Center
2244
mi
from 91732
Rochester, NY
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
James P. Wilmot Cancer Center at University of Rochester Medical Center
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Legacy Emanuel Hospital and Health Center & Children's Hospital
829
mi
from 91732
Portland, OR
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Legacy Emanuel Hospital and Health Center & Children's Hospital
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Penn State Children's Hospital
2295
mi
from 91732
Hershey, PA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Penn State Children's Hospital
2295
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Cook Children's Medical Center - Fort Worth
1195
mi
from 91732
Fort Worth, TX
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Cook Children's Medical Center - Fort Worth
1195
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
University of Texas Health Science Center at San Antonio
1183
mi
from 91732
San Antonio, TX
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
University of Texas Health Science Center at San Antonio
1183
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
Children's Hospital and Regional Medical Center - Seattle
964
mi
from 91732
Seattle, WA
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
Children's Hospital and Regional Medical Center - Seattle
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated:  10/5/2015
CancerCare Manitoba
1521
mi
from 91732
Winnipeg,
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Status: Enrolling
Updated: 10/5/2015
CancerCare Manitoba
1521
mi
from 91732
Winnipeg,
Click here to add this to my saved trials
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back
Status: Enrolling
Updated:  10/5/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back
Status: Enrolling
Updated: 10/5/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  10/5/2015
University of Chicago
1730
mi
from 91732
Chicago, IL
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 10/5/2015
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  10/5/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 10/5/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials